110 results
-
List item
Press release: European Medicines Agency finalises review of Baxter's dialysis solutions
CHMP, Last updated: 23/09/2011Agency finalises review of Baxter's dialysis solutions … Agency finalises review of Baxter's dialysis solutions … Agency finalises review of Baxter’s dialysis solutions … -
List item
Press release: Review of the manufacture of Baxter's peritoneal dialysis solutions initiated over potential presence of endotoxins in some batches
CHMP, Last updated: 21/01/2011Review of the manufacture of Baxter's peritoneal dialysis solutions … Review of the manufacture of Baxter's peritoneal dialysis solutions … Review of the manufacture of Baxter’s peritoneal dialysis solutions … -
List item
Press release: European Medicines Agency recommends action plan to deal with possible presence of endotoxins in Baxter peritoneal dialysis solutions
CHMP, Last updated: 17/12/2010presence of endotoxins in Baxter peritoneal dialysis solutions … Agency has been informed by Baxter of the potential presence … problem was detected when Baxter found during routine testing … -
List item
News: Public Statement on Trovan IV and Turvel IV
CHMP, Last updated: 25/02/1999for infusion with lactated Ringer's injection. The need to introduce … normal saline and lactated Ringer's injection. Specific changes … be diluted with lactated Ringer's normal saline, 0.9% sodium … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 October 2013
CHMP, Last updated: 25/10/2013Pandemic Influenza Vaccine Baxter H5N1 … -
List item
Press release: PRAC recommends suspending marketing authorisations for infusion solutions containing hydroxyethyl starch
PRAC, Last updated: 14/06/2013Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis … Hydroxyethyl Starch 130/0.42 versus Ringer’s acetate in severe sepsis … saline (salt) solutions or Ringer acetate, contain smaller … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 April 2011
CHMP, Last updated: 15/04/2011Update on review of Baxter's dialysis solutions … website. Update on review of Baxter’s dialysis solutions While … presence of endotoxins in Baxter’s dialysis solutions manufactured … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 January 2011
CHMP, Last updated: 21/01/2011presence of endotoxins in Baxter peritoneal dialysis solutions … presence of endotoxins in Baxter peritoneal dialysis solutions … Committee was informed by Baxter that the problem of endotoxins … -
List item
Press release: EMA starts new review of hydroxyethyl-starch containing medicines
PRAC, Last updated: 27/10/2017crystalloids, such as saline or Ringer's solutions, contain smaller … crystalloids, such as saline or Ringer’s solutions, contain smaller … -
List item
News: PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market
PRAC, Last updated: 11/02/2022substances and include saline and Ringer’s solutions. In the EU, HES … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 September 2011
CHMP, Last updated: 23/09/2011solutions produced at Castlebar Baxter group of companies and associated … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 December 2010
CHMP, Last updated: 17/12/2010Extraneal and Nutrineal, from Baxter. These are sterile solutions … Extraneal and Nutrineal, from Baxter. These are sterile solutions … -
List item
Press release: PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market
PRAC, Last updated: 12/01/2018crystalloids, such as saline or Ringer's solutions, are pure electrolyte … crystalloids, such as saline or Ringer’s solutions, are pure electrolyte … crystalloids, such as saline or Ringer’s solutions, are pure electrolyte … -
List item
Press release: PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients
PRAC, Last updated: 11/10/2013saline (salt) solutions or Ringer's acetate, contain smaller … saline (salt) solutions or Ringer’s acetate, contain smaller … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2011
CHMP, Last updated: 16/12/2011cell derived, inactivated) Baxter Innovations GmbH Zelboraf … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 October 2014
CHMP, Last updated: 24/10/2014Marketing-authorisation applicant Baxter Innovations GmbH Therapeutic … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 March 2013
CHMP, Last updated: 22/03/2013Marketing-authorisation applicant Baxter Innovations GmbH Therapeutic … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2016
CHMP, Last updated: 22/07/2016Marketing-authorisation applicant Baxter Innovations GmbH Therapeutic … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)20-23 June 2011
CHMP, Last updated: 24/06/2011normal immunoglobulin), from Baxter AG, to include the treatment … normal immunoglobulin), from Baxter AG, to include the treatment … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,15-18 December 2008
CHMP, Last updated: 18/12/2008derived, inactivated)), from Baxter AG. Pandemic vaccines are … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 February 2022
CHMP, Last updated: 25/02/2022Marketing-authorisation applicant Baxter Holding B.V. Therapeutic … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 June 2013
European Medicines Agency, London, UK, from 10/06/2013 to 13/06/2013, Last updated: 02/07/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 29-31 October 2012
European Medicines Agency, London, UK, from 29/10/2012 to 31/10/2012, Last updated: 03/12/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
Press release: European Medicines Agency updates on pandemic influenza
CHMP, Last updated: 22/01/2010